Anabolic Androgenic Steroid Use and Myocardial Flow Reserve Among Women - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Anabolic-Androgenic Steroid Use and Myocardial Flow Reserve in Women

  • By

  • Anders Kløve Petz

  • Yeliz Bulut

  • Niels Brandt-Jacobsen

  • Jon Jarløv Rasmussen

  • Jan Frystyk

  • Philip Hasbak

  • Caroline Kistorp

  • November 4, 2026

Share

Objective:

To examine whether current or former anabolic-androgenic steroid (AAS) use is associated with coronary microcirculation in women.

Approach:
  • Design and participants: Cross-sectional substudy of 54 resistance-training women without a history of cardiovascular disease: 20 current AAS users, 17 former users, and 17 never-users.
  • Assessment: Myocardial flow reserve (MFR) was measured using resting and adenosine-stressed rubidium-82 PET/CT as the ratio of stressed to resting myocardial blood flow.
Key Findings:
  • Mean MFR and the frequency of clinically or subclinically impaired MFR did not differ between AAS-use groups and controls.
  • Among former users, longer cumulative AAS exposure was associated with lower MFR; the association remained after adjustment for age and time since cessation.
  • Resting myocardial blood flow was lower in current users than in controls.
Interpretation:

The authors report no overall MFR difference among current users, former users, and nonusers, but found an association between longer AAS exposure and lower MFR among former users.

Limitations:
  • The cross-sectional design does not permit causal inference.
  • The sample size was small.
Conclusion:

Overall MFR did not differ by AAS-use history, while longer cumulative exposure was associated with lower MFR among former users.

Original Source(s)

Related Content